Tech Company Financing Transactions
Essentialis Funding Round
Essentialis secured a Series B financing round on 10/11/2010. Investors included Forward Ventures, Palo Alto Investors and Technology Partners.
Transaction Overview
Company Name
Announced On
10/11/2010
Transaction Type
Venture Equity
Amount
Unknown
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2011 Palomar Airport Rd. 108
Carlsbad, CA 92011
USA
Carlsbad, CA 92011
USA
Phone
Email Address
Overview
Essentialis is a pharmaceutical company focused on the development of breakthrough medicines for the treatment of cardiovascular and metabolic diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Scientific Officer
Neil Cowen
Browse more venture capital transactions:
Prev: 10/11/2010: BioSystem Development venture capital transaction
Next: 10/11/2010: TriReme Medical venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs